Genpact Limited (NYSE:G) Shares Sold by Cornercap Investment Counsel Inc.

Cornercap Investment Counsel Inc. cut its stake in Genpact Limited (NYSE:G - Free Report) by 42.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,014 shares of the business services provider's stock after selling 6,759 shares during the quarter. Cornercap Investment Counsel Inc.'s holdings in Genpact were worth $387,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. SRH Advisors LLC acquired a new stake in shares of Genpact during the 4th quarter valued at about $26,000. Manchester Capital Management LLC purchased a new position in Genpact during the fourth quarter worth approximately $38,000. Smartleaf Asset Management LLC grew its holdings in Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares during the period. UMB Bank n.a. increased its position in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after buying an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp raised its stake in shares of Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after buying an additional 453 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on G shares. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Needham & Company LLC raised their price target on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Finally, Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $48.44.

Insider Buying and Selling

In other news, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company's stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by company insiders.

Genpact Price Performance

Shares of Genpact stock traded down $1.98 on Thursday, hitting $48.55. 314,504 shares of the company were exchanged, compared to its average volume of 1,346,301. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company has a 50-day moving average price of $51.13 and a 200 day moving average price of $45.31. The stock has a market capitalization of $8.53 billion, a price-to-earnings ratio of 17.10, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. Genpact Limited has a 1-year low of $30.23 and a 1-year high of $56.76.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, sell-side analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.40%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is currently 23.94%.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.